KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $44.4 million.

  • Aurinia Pharmaceuticals' Free Cash Flow rose 16194.52% to $44.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.9 million, marking a year-over-year increase of 32715.42%. This contributed to the annual value of $44.1 million for FY2024, which is 22904.71% up from last year.
  • Aurinia Pharmaceuticals' Free Cash Flow amounted to $44.4 million in Q3 2025, which was up 16194.52% from $44.1 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Free Cash Flow ranged from a high of $44.4 million in Q3 2025 and a low of -$54.6 million during Q1 2021
  • Moreover, its 5-year median value for Free Cash Flow was -$13.2 million (2023), whereas its average is -$7.3 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 6336511.63% in 2021, then skyrocketed by 62331.0% in 2024.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' Free Cash Flow stood at -$25.9 million in 2021, then skyrocketed by 139.8% to $10.3 million in 2022, then skyrocketed by 35.84% to $14.0 million in 2023, then skyrocketed by 114.5% to $30.1 million in 2024, then soared by 47.66% to $44.4 million in 2025.
  • Its Free Cash Flow was $44.4 million in Q3 2025, compared to $44.1 million in Q2 2025 and $1.3 million in Q1 2025.